Mercury Toxicity: Evaluation and Management
For suspected mercury toxicity, immediately remove the patient from exposure, obtain blood and 24-hour urine mercury levels, and initiate chelation therapy with DMSA (succimer) or DMPS (unithiol) for symptomatic patients or those with significantly elevated mercury levels, while avoiding chelation in asymptomatic patients with low-level chronic exposure.
Initial Assessment and Diagnosis
Clinical Presentation by Mercury Form
Acute elemental/metallic mercury vapor inhalation presents with:
- Respiratory symptoms: cough, dyspnea, chest pain, potential acute pneumonitis
- Can progress to respiratory failure requiring high-flow oxygen support 1
- Patients with these symptoms require immediate emergency department evaluation regardless of reported dose 2
Chronic elemental mercury exposure manifests as:
- Neurological: tremor, personality changes, headache
- Dermatological: rash
- Constitutional: anorexia, weight loss, myalgias
- Cardiovascular: hypertension 3
Inorganic mercury compounds (e.g., mercuric chloride) cause:
- Gastrointestinal: severe abdominal pain, vomiting, gastrointestinal bleeding
- Renal: acute kidney injury
- Colonic mucosal necrosis
- Can cross blood-brain barrier (mercury detected in CSF at 5.45 μg/L in one case) 4
Diagnostic Testing
Obtain these specific tests:
- 24-hour urine mercury concentration: Symptomatic patients typically have levels >20 mcg/L 3
- Blood mercury levels: Confirms acute exposure
- Serum creatinine: Assess renal function
- Chest imaging: If respiratory symptoms present
- CSF mercury levels: Consider if neurological symptoms present 4
Immediate Management by Exposure Type
High-Risk Exposures Requiring Emergency Evaluation
Heated mercury in enclosed spaces: All exposed individuals need healthcare facility evaluation due to high toxicity risk 2
Ingestion >1 household thermometer amount or abdominal pain post-ingestion: Emergency department referral 2
Soft tissue injection/deposition: Surgical evaluation for removal 2
Self-harm or malicious administration: Immediate emergency department referral 2
Decontamination
- Dermal exposure: Remove all jewelry, wash with mild soap and water, double-bag contaminated clothing 2
- Do NOT induce emesis or give activated charcoal 2
- Environmental cleanup: Professional remediation for spills larger than a thermometer; never use vacuum cleaners or brooms 2
Chelation Therapy
Indications for Chelation
Chelation is indicated for:
- Symptomatic acute mercury poisoning
- Significantly elevated mercury levels with symptoms
- Treatment should begin within minutes to hours of acute exposure for maximum efficacy 5
Chelation is NOT recommended for:
- Asymptomatic individuals with low blood mercury concentrations 6
- Chronic low-level exposure without symptoms
Chelating Agent Selection
DMSA (succimer) or DMPS (unithiol) are preferred over BAL because they:
- Have higher therapeutic index
- Do not redistribute mercury to the brain
- Can be administered orally
- Have relatively low toxicity 7, 5
Treatment Protocols
For acute severe poisoning (e.g., mercuric chloride ingestion):
- DMPS chelation therapy
- Consider continuous renal replacement therapy (CRRT) combined with CytoSorb for severe cases with renal injury 4
For acute pneumonitis from mercury vapor:
- High-dose methylprednisolone (500 mg IV daily) if no response to lower doses (80 mg daily)
- Concurrent chelation therapy
- Monitor for 6 months post-discharge for residual pulmonary fibrotic changes 1
For symptomatic chronic exposure:
- DMSA chelation resulted in symptom resolution within 6 months when combined with exposure removal 3
Critical Timing Considerations
Chelation efficacy declines dramatically with time - effectiveness decreases or disappears as the interval between exposure and treatment initiation increases beyond a few hours 5. This underscores the importance of rapid diagnosis and treatment initiation.
Monitoring and Follow-Up
Symptomatic patients require:
- Serial mercury levels (blood and urine) during treatment
- Renal function monitoring
- Pulmonary function tests if respiratory involvement
- 6-month follow-up for complete recovery assessment 1
Asymptomatic patients with chronic exposure concerns:
- Non-urgent outpatient evaluation if high-dose or chronic duration exposure 2
Special Populations
Pregnant patients:
- Asymptomatic with unintentional exposure: Outpatient obstetric evaluation, not emergency department 2
- Should avoid occupational exposure resulting in blood lead >5 μg/dL (extrapolating from lead guidelines) 6
Common Pitfalls
- Delayed diagnosis: Mercury toxicity has nonspecific symptoms; maintain high index of suspicion 3
- Inadequate corticosteroid dosing: In acute pneumonitis, escalate to high-dose (500 mg) if no response to standard doses 1
- Inappropriate chelation: Avoid in asymptomatic low-level chronic exposure - no proven benefit 5
- Environmental contamination: Requires multidisciplinary approach with public health officials for proper remediation 3